163 related articles for article (PubMed ID: 35609863)
1. Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model.
Pupyshev AB; Belichenko VM; Tenditnik MV; Bashirzade AA; Dubrovina NI; Ovsyukova MV; Akopyan AA; Fedoseeva LA; Korolenko TA; Amstislavskaya TG; Tikhonova MA
Pharmacol Biochem Behav; 2022 Jun; 217():173406. PubMed ID: 35609863
[TBL] [Abstract][Full Text] [Related]
2. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
[TBL] [Abstract][Full Text] [Related]
3. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.
Spilman P; Podlutskaya N; Hart MJ; Debnath J; Gorostiza O; Bredesen D; Richardson A; Strong R; Galvan V
PLoS One; 2010 Apr; 5(4):e9979. PubMed ID: 20376313
[TBL] [Abstract][Full Text] [Related]
5. Restoration of Parkinson's Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson's Disease in Mice.
Pupyshev AB; Tenditnik MV; Ovsyukova MV; Akopyan AA; Dubrovina NI; Tikhonova MA
Bull Exp Biol Med; 2021 Aug; 171(4):425-430. PubMed ID: 34542745
[TBL] [Abstract][Full Text] [Related]
6. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease.
Jiang T; Yu JT; Zhu XC; Tan MS; Wang HF; Cao L; Zhang QQ; Shi JQ; Gao L; Qin H; Zhang YD; Tan L
Pharmacol Res; 2014 Mar; 81():54-63. PubMed ID: 24602800
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
Wang C; Zhang X; Teng Z; Zhang T; Li Y
Eur J Pharmacol; 2014 Oct; 740():312-20. PubMed ID: 25041840
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
Witucki Ł; Borowczyk K; Suszyńska-Zajczyk J; Warzych E; Pawlak P; Jakubowski H
J Alzheimers Dis; 2023; 95(4):1735-1755. PubMed ID: 37718819
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
[TBL] [Abstract][Full Text] [Related]
10. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway.
Wang X; Jia J
Biomed Pharmacother; 2023 May; 161():114473. PubMed ID: 36889111
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
Chen J; Long Z; Li Y; Luo M; Luo S; He G
Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of early neurodegeneration signs in a mouse model of Alzheimer's disease-like pathology induced by two types of the central (Intracerebroventricular vs. Intrahippocampal) administration of Aβ
Belichenko VM; Bashirzade AA; Tenditnik MV; Dubrovina NI; Akopyan AA; Ovsyukova MV; Fedoseeva LA; Pupyshev AB; Aftanas LI; Amstislavskaya TG; Tikhonova MA
Behav Brain Res; 2023 Oct; 454():114651. PubMed ID: 37657512
[TBL] [Abstract][Full Text] [Related]
13. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.
Caccamo A; Majumder S; Richardson A; Strong R; Oddo S
J Biol Chem; 2010 Apr; 285(17):13107-20. PubMed ID: 20178983
[TBL] [Abstract][Full Text] [Related]
14. Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice.
Korolenko TA; Dubrovina NI; Ovsyukova MV; Bgatova NP; Tenditnik MV; Pupyshev AB; Akopyan AA; Goncharova NV; Lin CL; Zavjalov EL; Tikhonova MA; Amstislavskaya TG
Cells; 2021 Sep; 10(10):. PubMed ID: 34685538
[TBL] [Abstract][Full Text] [Related]
15. S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.
Wang X; Huang R; Huang B; Li X
J Alzheimers Dis; 2023; 96(4):1489-1504. PubMed ID: 38007654
[TBL] [Abstract][Full Text] [Related]
16. [Effect of mammalian target of rapamycin on cognitive dysfunction of Alzheimer's Disease via regulating Homer3].
Huang YQ; Liu XG; Zhang L; Yu Y; Xue J; Sun JL
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1336-1340. PubMed ID: 32375443
[No Abstract] [Full Text] [Related]
17. Alimentary Treatment with Trehalose in a Pharmacological Model of Alzheimer's Disease in Mice: Effects of Different Dosages and Treatment Regimens.
Pupyshev AB; Akopyan AA; Tenditnik MV; Ovsyukova MV; Dubrovina NI; Belichenko VM; Korolenko TA; Zozulya SA; Klyushnik TP; Tikhonova MA
Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931934
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation and autophagy modulation debilitates insulin resistance associated Alzheimer's disease condition in rats.
Kakoty V; K C S; Dubey SK; Yang CH; Marathe SA; Taliyan R
Metab Brain Dis; 2022 Apr; 37(4):927-944. PubMed ID: 35064868
[TBL] [Abstract][Full Text] [Related]
19. Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease.
Zhang Z; Wang X; Zhang D; Liu Y; Li L
Aging (Albany NY); 2019 Jan; 11(2):536-548. PubMed ID: 30684442
[TBL] [Abstract][Full Text] [Related]
20. Disaccharide trehalose in experimental therapies for neurodegenerative disorders: Molecular targets and translational potential.
Pupyshev AB; Klyushnik TP; Akopyan AA; Singh SK; Tikhonova MA
Pharmacol Res; 2022 Sep; 183():106373. PubMed ID: 35907433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
